SCHEMBL20008452

SCHEMBL20008452

COc1cc(-c2cc(C)ccc2C)cc(N2CCCCC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GALR2 O43603 2/20 0.44
▸ KDM4E B2RXH2 8/20 0.40
▸ L3MBTL1 Q9Y468 6/20 0.40
▸ GAA P10253 4/20 0.40
▸ ACHE P22303 1/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ TDP1 Q9NUW8 3/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ USP2 O75604 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MAPK1 P28482 3/20 0.38
▸ CRHBP P24387 1/20 0.38
▸ CRHR2 Q13324 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ ALPL P05186 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008122 0.82 SMN1; SMN2 (0.46) KDM4EL3MBTL1GAAACHETDP1
SCHEMBL20008237 0.76 HRH4 (0.47) —
SCHEMBL22488129 0.76 RAF1 (0.58) KDM4EGAAALDH1A1SMN1; SMN2CRHBP
SCHEMBL20008538 0.76 DRD2 (0.49) GALR2KDM4EL3MBTL1GAAACHE
SCHEMBL17696413 0.76 SMN1; SMN2 (0.46) KDM4EL3MBTL1GAAACHEALDH1A1
SCHEMBL20009412 0.75 RAF1 (0.40) KDM4EL3MBTL1GAAACHEMAPK1
SCHEMBL20009114 0.75 BRAF (0.57) —
SCHEMBL19529392 0.75 RAF1 (0.40) GALR2KDM4EL3MBTL1GAAACHE
SCHEMBL20009430 0.74 RAF1 (0.49) KDM4EL3MBTL1GAAACHEMAPK1
SCHEMBL20008460 0.73 RAF1 (0.41) KDM4EL3MBTL1GAAACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3299367-A1 BIARYL AMIDE COMPOUNDS AS KINASE INHIBITORS Novartis AG (CH) 2018-03-28 — — EP disclosed
Send feedback